Alterations in the Intraocular Cytokine Milieu after Intravitreal Bevacizumab
Authors:
Open Access
- 1 May 2010
- journal article
- research article
- Published by Association for Research in Vision and Ophthalmology (ARVO) in Investigative Ophthalmology & Visual Science
- Vol. 51 (5) , 2388-2392
Abstract
Purpose.: Several complications after intravitreal bevacizumab (IVB) treatment have been described including tears of the retinal pigment epithelium and tractional retinal detachment. The etiology of these complications remains unclear. The purpose of this study was to characterize changes in the intraocular levels of inflammatory cytokines after IVB as a possible explanation for these complications. Methods.: Twenty-nine patients with proliferative diabetic retinopathy (PDR) undergoing pars plana vitrectomy (PPV) for vitreous hemorrhage (VH) with IVB pretreatment were prospectively enrolled. Aqueous humor samples were taken at the time of IVB pretreatment and approximately 1 week later at the time of PPV. Multiplex cytokine arrays were used to assay 20 different cytokines. Multivariate general linear regression was performed to determine differences in cytokine levels between the two study visits. Proportional hazards regression was performed to determine the relationship between cytokine levels at PPV and postoperative outcomes. Results.: After treatment with IVB, vascular endothelial growth factor (VEGF) concentrations in the aqueous humor decreased (P = 0.0003), whereas the concentrations of IL-8 and transforming growth factor (TGF)-β2 increased after IVB (P < 0.03). The level of IL-8 at the time of PPV was associated with the occurrence of recurrent VH after surgery (hazard ratio, 1.32; P = 0.02). Conclusions.: Alterations in the intraocular inflammatory cytokine milieu occur after IVB injection, possibly as a compensatory mechanism in response to VEGF inhibition. The increased concentrations of inflammatory cytokines after IVB may be clinically significant and may be responsible for some of the complications after IVB.Keywords
This publication has 51 references indexed in Scilit:
- Intraocular Concentrations of Growth Factors and Cytokines in Retinal Vein Occlusion and the Effect of Therapy with BevacizumabInvestigative Ophthalmology & Visual Science, 2009
- Role of TGF-β in proliferative vitreoretinal diseases and ROCK as a therapeutic targetProceedings of the National Academy of Sciences, 2008
- Pathways Mediating Resistance to Vascular Endothelial Growth Factor–Targeted TherapyClinical Cancer Research, 2008
- Potent Inhibition of Cicatricial Contraction in Proliferative Vitreoretinal Diseases by StatinsDiabetes, 2008
- The discovery of the placental growth factor and its role in angiogenesis: a historical reviewAngiogenesis, 2008
- Interleukin‐8 increases vascular endothelial growth factor and neuropilin expression and stimulates ERK activation in human pancreatic cancerCancer Science, 2008
- Multiple circulating proangiogenic factors induced by sunitinib malate are tumor-independent and correlate with antitumor efficacyProceedings of the National Academy of Sciences, 2007
- AZD2171, a Pan-VEGF Receptor Tyrosine Kinase Inhibitor, Normalizes Tumor Vasculature and Alleviates Edema in Glioblastoma PatientsCancer Cell, 2007
- Angiogenesis in life, disease and medicineNature, 2005
- Vitreous leptin levels in retinal diseaseEye, 2005